News Mar 13, 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
News Mar 26, 2024 Zurich researchers make cancer therapy effective again Researchers from the University of Zurich and University Hospital Zurich have discovered how mutated blood cancer cells can be made to respond to...
News May 26, 2023 Researchers at Kantonsspital St.Gallen find new approach for brain tumors St.Gallen - An international team of scientists led by Kantonsspital St.Gallen have developed new research approaches to combat malignant brain t...
News Jan 29, 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News Feb 20, 2023 Limula and CSEM collaborate to make cellular therapies more accessible To improve the accessibility of cellular therapies using automation, Limula has received support from the CSEM from the prototyping phase to the ...
Actualités Jul 06, 2022 Qarad, société du groupe QbD, s’installe en Suisse Le spécialiste belge du diagnostic in vitro, Qarad, est votre porte d'entrée en Europe pour les diagnostics in vitro et les dispositifs médicaux....
News Oct 27, 2023 UZH researchers develop method for transport of large genes Researchers at the University of Zurich (UZH) have developed a new method for transporting large genes, enabling them to be transferred efficient...
News Aug 08, 2022 HSG spin-off takes root in the USA CollectID from the canton of St.Gallen has developed a blockchain-based technology for registering individual pieces to improve detection of fake...
News Jul 06, 2022 Qarad, part of the QbD Group, expands to Switzerland Belgian-based IVD specialist Qarad is your gateway to Europe for In Vitro Diagnostics and Medical Devices. The company has recently opened a new ...
News Oct 18, 2023 Cimeio collaborating with the University of Pennsylvania The Basel-based start-up Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Penns...
News Oct 10, 2023 Nagi Bioscience secures CHF 12.4 million to propel animal-alternative testing Propelling the momentum towards humane, next-gen laboratory solutions, Nagi Bioscience has secured CHF 12.4 million to open doors to new markets ...
News Oct 20, 2023 Lonza expands to manufacture Vaxcyte’s pneumococcal conjugate vaccine Lonza and US clinical-stage vaccine innovation company Vaxcyte have announced an expansion in their partnership to establish a global commercial ...
News Oct 18, 2023 BioArk Monthey’s third building signifies exponential growth in the life sciences sector With two decades under its belt, the BioArk site in Monthey continues to cement its position as a front-runner in life sciences.
Analisi Mar 22, 2021 Marketing digitale B2B in China Il panorama digitale in Cina è unico e in rapida evoluzione, molto diverso da quello europeo. Per scoprire come se la cavano le aziende svizzere ...
News Nov 30, 2021 Hemex banks 7.1 million Swiss francs Hemex has raised a total of 7.1 million Swiss francs as part of a Series C financing round. The company for clinical contract research and invest...
Actualités May 18, 2021 Le Start-Up Fund du Biopôle veut favoriser un accès précoce à l’innovation dans les sciences de la vie Biopôle a annoncé le lancement du « Biopôle Start-Up Fund », un nouveau fonds dédié au soutien de la prochaine génération d’entrepreneurs dans le...